Sequential soxhlet fractionation of Cistus ladanifer L. reveals a polarity–activity gradient: GC-MS profiling, multimechanistic bioactivity, and in silico identification of antifungal and antibacterial lead compounds

Résumé

Introduction AMR and oxidative stress are among the most pressing biomedical challenges, requiring structurally novel multi-target bioactive molecules. Cistus ladanifer L. is an ethnobotanical resource whose polarity-resolved phytochemical profile remains largely incomplete. Methods C. ladanifer leaves (Rmilate forest, Tangier) were fractionated by sequential Soxhlet extraction (n-hexane, chloroform, ethanol, water) and evaluated by phytochemical quantification, FTIR, GC-MS, four antioxidant assays (DPPH, ABTS, FRAP, ORAC), antibacterial well-diffusion/microdilution ( S. aureus, B. subtilis, E. coli, P. aeruginosa ), antifungal assays ( T. rubrum, M. canis, B. cinerea, F. oxysporum ), and ADMET/docking of four marker compounds (EOMCP, DHMAQ, esculin, diosgenin). Results A strict polarity-dependent gradient was observed, with the aqueous fraction showing the highest phenolic (140 mg GAE/g DW), flavonoid (148 mg QE/g DW), and tannin (210 mg TAE/g DW) content; strongest antioxidant activity (DPPH IC50 = 0.09 mg/mL; FRAP = 65.25 mg TE/g DW); lowest MIC (0.25 mg/mL, bactericidal, MBC/MIC ≤4); and highest antifungal inhibition (86.0% against T. rubrum at 4 mg/mL). Diosgenin showed the strongest docking affinity against CYP51B (5FRB, −12.7 kcal/mol), exceeding the reference ligand. Discussion These findings establish a polarity–activity framework supporting C. ladanifer's valorization as an antioxidant, antibacterial, and antifungal resource, pending cytocompatibility and in vivo evaluation.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0